Target
Cytochrome P450 2D6
Ligand
BDBM50614666
Substrate
n/a
Meas. Tech.
ChEMBL_2298108
IC50
40000±n/a nM
Citation
 Jurica, EAWu, XWilliams, KNHaque, LERampulla, RAMathur, AZhou, MCao, GCai, HWang, TLiu, HXu, CKunselman, LKAntrilli, TMHicks, MBSun, QDierks, EAApedo, AMoore, DBFoster, KACvijic, MEPanemangalore, RKhandelwal, PWilkes, JJZinker, BARobertson, DGJanovitz, EBGalella, MLi, YXLi, JRamar, TJalagam, PRJayaram, RWhaley, JMBarrish, JCRobl, JAEwing, WREllsworth, BA Optimization of physicochemical properties of pyrrolidine GPR40 AgoPAMs results in a differentiated profile with improved pharmacokinetics and reduced off-target activities. Bioorg Med Chem 85:0 (2023) [PubMed] 
Target
Name:
Cytochrome P450 2D6
Synonyms:
CP2D6_HUMAN | CYP2D6 | CYP2DL1 | CYPIID6 | Cytochrome P450 2D6 (CYP2D6) | Debrisoquine 4-hydroxylase | P450-DB1
Type:
Protein
Mol. Mass.:
55774.82
Organism:
Homo sapiens (Human)
Description:
P10635
Residue:
497
Sequence:
MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVDFQNTPYCFDQLRRRFGDVFSLQLAWTPVVVLNGLAAVREALVTHGEDTADRPPVPITQILGFGPRSQGVFLARYGPAWREQRRFSVSTLRNLGLGKKSLEQWVTEEAACLCAAFANHSGRPFRPNGLLDKAVSNVIASLTCGRRFEYDDPRFLRLLDLAQEGLKEESGFLREVLNAVPVLLHIPALAGKVLRFQKAFLTQLDELLTEHRMTWDPAQPPRDLTEAFLAEMEKAKGNPESSFNDENLRIVVADLFSAGMVTTSTTLAWGLLLMILHPDVQRRVQQEIDDVIGQVRRPEMGDQAHMPYTTAVIHEVQRFGDIVPLGVTHMTSRDIEVQGFRIPKGTTLITNLSSVLKDEAVWEKPFRFHPEHFLDAQGHFVKPEAFLPFSAGRRACLGEPLARMELFLFFTSLLQHFSFSVPTGQPRPSHHGVFAFLVSPSPYELCAVPR
  
Inhibitor
Name:
BDBM50614666
Synonyms:
CHEMBL5285988
Type:
Small organic molecule
Emp. Form.:
C29H40ClN3O6
Mol. Mass.:
562.097
SMILES:
COCCCO[C@H]1CN([C@@H](CC(O)=O)[C@@H]1C)c1ccc(O[C@@H]2CCN(C[C@H]2C)c2cc(OC)ncc2Cl)cc1 |r|
Structure:
Search PDB for entries with ligand similarity: